Trends in mortality from leukemia in Europe: an update to 2009 and a projection to 2012

International Journal of Cancer. Journal International Du Cancer
Paola BertuccioCarlo La Vecchia

Abstract

We considered trends in mortality from leukemia in Europe over the period 1970-2009 using data from the World Health Organization. We computed age-standardized (world population) mortality rates, at all ages and in selected age groups, in 11 selected European countries, the European Union (EU) and, for comparative purposes, in the USA and Japan. For the EU, we also provided projections of the mortality to 2012. Over the period considered, mortality from leukemia steadily declined in most European countries in children and young adults, as well as in western and southern Europe at middle-age (45-69 years); in central/eastern Europe, reductions at ages 45-69 started since the mid-late 1990s. In the EU, annual percent changes were -3.7% in males and -3.8% in females at age 0-14, -2% in both sexes at age 15-44, and -0.6% in males and -1% in females at middle-age and overall. No decline was observed at age 70 or more. Between 1997 and 2007, overall EU rates decreased from 5.4 to 4.8/100,000 males and from 3.4 to 2.9/100,000 females. Declines were from 6.2 to 5.5/100,000 males and from 3.7 to 3.2/100,000 females in the USA and from 3.9 to 3.5/100,000 males and from 2.5 to 2.0/100,000 females in Japan. Projected overall rates in the E...Continue Reading

References

Nov 9, 2000·Leukemia·F LeviC La Vecchia
Jan 5, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F LeviC La Vecchia
Apr 16, 2002·Current Problems in Pediatric and Adolescent Health Care·Ka Wah Chan
Mar 14, 2003·Cancer Treatment Reviews·Uday PopatHelen E Heslop
Oct 10, 2003·The New England Journal of Medicine·John M Goldman, Junia V Melo
Apr 14, 2007·Cancer·Elias JabbourHagop M Kantarjian
Oct 27, 2007·British Journal of Haematology·Rebecca L AuerFinbarr E Cotter
Oct 31, 2007·Bone Marrow Transplantation·A K Fielding, A H Goldstone
Jun 28, 2008·Nutrition and Cancer·John P RichieJoshua E Muscat
Sep 11, 2008·Journal of the National Cancer Institute·Alan S WayneLee J Helman
Oct 11, 2008·International Journal of Cancer. Journal International Du Cancer·Dongmei QiuTomotaka Sobue
Jan 28, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Milena SantUNKNOWN EUROCARE Working Group
Mar 14, 2009·The Oncologist·Heidi D Klepin, Lodovico Balducci
Oct 13, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Cristina BosettiCarlo La Vecchia
Oct 27, 2009·Statistics in Medicine·Limin X CleggBrenda K Edwards
Dec 2, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C La VecchiaF Levi
Jul 16, 2010·Cancer·Liliane ChatenoudCarlo La Vecchia
Feb 10, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M MalvezziE Negri
Mar 10, 2011·Cancer·Gunnar JuliussonUNKNOWN Swedish Acute Leukemia Registry Group, the Swedish Acute Myeloid Leukemia Group, the Swedish Adult Acute Lymphoblastic Leuke
Apr 2, 2011·Journal of the National Cancer Institute·Betsy A KohlerBrenda K Edwards
Jul 29, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E C van den BroekE F M Posthuma
Jan 28, 2012·Critical Reviews in Oncology/hematology·Massimo BrecciaGiuliana Alimena
Jan 1, 2011·Revista brasileira de hematologia e hemoterapia·Nadjanara Dorna BuenoDalton de Alencar Fischer Chamone

❮ Previous
Next ❯

Citations

Apr 11, 2014·BMC Cancer·Roberto Pastor-Barriuso, Gonzalo López-Abente
Aug 8, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C BosettiC La Vecchia
Apr 25, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M MalvezziE Negri
Dec 18, 2013·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·J RibesJ M Borras
Jan 28, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M MalvezziE Negri
Jul 22, 2014·BioMed Research International·Wei GaoThian-Sze Wong
Apr 8, 2017·Journal of X-ray Science and Technology·Fenglin LiuYufang Cai
Jul 13, 2016·The Oncologist·Carlo La Vecchia, Pierfranco Conte
Jul 30, 2016·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Tiziana RossoCarlo La Vecchia
Nov 9, 2020·BMC Pediatrics·J Smith Torres-RomanDyego Leandro Bezerra de Souza
Dec 29, 2020·Frontiers in Public Health·Baojing LiHao Xiang

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Cancer. Journal International Du Cancer
Cristina BosettiCarlo La Vecchia
Molecular Carcinogenesis
Cristina BosettiPaolo Boffetta
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Cristina BosettiCarlo La Vecchia
Annals of Oncology : Official Journal of the European Society for Medical Oncology
Cristina BosettiCarlo La Vecchia
© 2021 Meta ULC. All rights reserved